Research Analysts Offer Predictions for Liquidia Q1 Earnings

Liquidia Corporation (NASDAQ:LQDA) – Analysts at HC Wainwright lowered their Q1 2026 earnings estimates for shares of Liquidia in a research report issued to clients and investors on Friday, March 6th. HC Wainwright analyst A. Fein now anticipates that the company will earn $0.35 per share for the quarter, down from their previous forecast of $0.43. HC Wainwright currently has a “Buy” rating and a $55.00 target price on the stock. The consensus estimate for Liquidia’s current full-year earnings is ($1.51) per share. HC Wainwright also issued estimates for Liquidia’s Q2 2026 earnings at $0.49 EPS and Q4 2026 earnings at $0.86 EPS.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings results on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.07. The firm had revenue of $92.02 million during the quarter, compared to analyst estimates of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The business’s quarterly revenue was up 3072.4% on a year-over-year basis.

Several other brokerages also recently weighed in on LQDA. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a research note on Thursday, January 22nd. Raymond James Financial reissued a “strong-buy” rating on shares of Liquidia in a research note on Thursday. Wall Street Zen raised shares of Liquidia from a “hold” rating to a “buy” rating in a report on Saturday. BTIG Research increased their price objective on shares of Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a report on Thursday. Finally, Zacks Research downgraded shares of Liquidia from a “strong-buy” rating to a “hold” rating in a report on Friday, February 27th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Liquidia currently has a consensus rating of “Moderate Buy” and a consensus target price of $42.00.

Liquidia Stock Performance

Shares of LQDA stock opened at $36.03 on Monday. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. Liquidia has a 12-month low of $11.26 and a 12-month high of $46.67. The business’s 50 day moving average is $37.10 and its two-hundred day moving average is $30.95. The company has a market capitalization of $3.17 billion, a P/E ratio of -43.41 and a beta of 0.53.

Insider Activity

In related news, CAO Dana Boyle sold 1,580 shares of the stock in a transaction on Monday, January 26th. The stock was sold at an average price of $41.65, for a total value of $65,807.00. Following the completion of the transaction, the chief accounting officer directly owned 178,848 shares of the company’s stock, valued at approximately $7,449,019.20. This represents a 0.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jason Adair sold 688 shares of the firm’s stock in a transaction on Monday, January 26th. The shares were sold at an average price of $41.65, for a total value of $28,655.20. Following the completion of the transaction, the insider owned 211,169 shares in the company, valued at $8,795,188.85. The trade was a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 212,534 shares of company stock valued at $7,964,719 in the last three months. Company insiders own 30.10% of the company’s stock.

Institutional Trading of Liquidia

Several hedge funds have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Liquidia by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after buying an additional 1,700 shares during the period. Goldman Sachs Group Inc. increased its holdings in Liquidia by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after purchasing an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Liquidia by 15.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after purchasing an additional 16,022 shares during the last quarter. Teacher Retirement System of Texas raised its position in Liquidia by 25.4% in the second quarter. Teacher Retirement System of Texas now owns 17,185 shares of the company’s stock valued at $214,000 after purchasing an additional 3,478 shares during the period. Finally, Tyro Capital Management LLC purchased a new stake in Liquidia in the second quarter valued at approximately $15,473,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Key Headlines Impacting Liquidia

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Commercial momentum and profitability — Liquidia reported YUTREPIA net product sales of $90.1M in Q4 and $148.3M for 2025, achieved a second consecutive profitable quarter (Q4 net income $14.6M) and positive adjusted EBITDA, signaling rapid launch adoption and improving unit economics. GlobeNewswire Release
• Positive Sentiment: Balance sheet strength — the company ended 2025 with ~$190.7M in cash, improving liquidity and backing management’s plan to fund commercial expansion and clinical programs from operations. Quiver Quant Summary
• Positive Sentiment: Analyst upgrades and higher price targets — several firms raised ratings/targets after the quarter (HC Wainwright to $55, Needham to $54, BTIG to $50, Wells Fargo to $44), which supports further upside and likely contributed to intraday buying. Benzinga Analyst Roundup
• Neutral Sentiment: Mixed EPS headlines — Liquidia reported GAAP EPS of $0.15 for Q4. That missed some sell‑side consensus figures (~$0.33) but beat other estimates (Zacks cited $0.08), creating mixed investor interpretation of the results. Zacks Coverage
• Neutral Sentiment: Earnings materials and management commentary available — the slide deck and transcript provide color on commercial adoption, prescriber metrics and plans to fund L606 and other programs; useful for assessing sustainability of the launch. Earnings Presentation (Seeking Alpha)
• Negative Sentiment: Initial market reaction to the EPS headline — shares gapped down on the earnings headline before rebounding, showing sensitivity to EPS versus revenue/profitability nuance. That initial gap indicates headline risk if future quarters miss expectations. DefenseWorld: Gap Down
• Negative Sentiment: Insider and institutional sales — recent filings and summaries show notable insider sell activity and some large institutional reductions, which can weigh on sentiment if sustained. Fool: SEC Filing

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).